Naomi et al. (32) reported the application of serum biomarkers (SB), including serum NGAL and serum creatinine, for the prediction of AKI in 52 COVID-19 patients, with AUCs of 0.81 and 0.87, respectively. Here, LCN2 is linked to acute kidney injury.